Hormone Replacement Therapy is to reach USD 22.31 billion by 2021 at a CAGR of 7.21% from 2016 to 22

Hormone replacement therapy (HRT) is employed in patients suffering from declining levels of hormones with the right administration of hormones into the body. These therapies are generally meted out to women undergoing menopause. Estrogen is among the most commonly administered hormones. However, progesterone and testosterone are also administered when needed.

Growing awareness on post-menopausal hazards, reimbursement policies, novel formulations, rise in unmet medical needs which require the employment of hormone therapy, benefits like lower risk of fractures are the few factors propelling the growth of global hormone replacement therapy market.
Responsible for more than half of the market revenues, the estrogen replacement therapy segment dominates the global HRT market. The largest consumers of estrogen replacement therapy are post-menopausal women.

Free sample for the report is available at http://www.marketdataforecast.com/market-reports/global-hormone-replacement-therapy-market-957/request-sample

North America dominated the market, where the majority of the contribution was from the USA owing to the well-established healthcare system. While, the market in the APAC region is expected to witness a rapid growth during the forecast period.

The Hormone Replacement Therapy Market is segmented as following:
Based on Hormone Type:
 Estrogen Replacement Therapy
 Growth Hormone Replacement Therapy
 Thyroid Replacement Therapy
 Others

Based on Route of Administration
 Oral
 Parenteral
 Transdermal
 Others

Geographical Segmentation:
 North America Hormone Replacement Therapy Market
 Europe Hormone Replacement Therapy Market
 Asia-Pacific Hormone Replacement Therapy Market
 Latin America Hormone Replacement Therapy Market
 Middle-East & Africa Hormone Replacement Therapy Market

The major companies operating in the hormone replacement industry are Abbott Laboratories (U.S.), Novartis (Switzerland), Pfizer (U.S.), Mylan Laboratories (U.S.), Amgen (U.S.), Merck & Co. (U.S.), Bayer (Germany), Eli Lily (U.S.), Novo Nordisk (Denmark), Wyeth (U.S.), F. Hoffmann-La Roche (Switzerland), and Hisamitsu Pharmaceutical Co. Inc. (Japan).

About Market Data Forecast:
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and

Contact:
Market Data Forecast,
kondapur,
hyderabad,
Hyderabad – 500084,
Andhra Pradesh, India,
Phone: (+91) – 7799555346,
E-Mail: thirupathi@marketdataforecast.com
http://www.marketdataforecast.com

 

Leave a Reply

Your email address will not be published. Required fields are marked *